Level D· Scientific groundwork from lab and animal studiesLaboratory StudyPubMedOpen access

Comparison of TGF-β3 and avocado/soybean unsaponifiable on chondrogenesis of human adipose-derived stem cells on poly (lactic-co-glycolic) acid/ hyaluronic acid hybrid scaffold.

Pourentezari M., Sharifian Z., Mardani M., Valiani A., Zamani Rarani M., Setayeshmehr M.

Laboratory Study, published in Iran J Basic Med Sci (2021) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Laboratory Study
Journal
Iran J Basic Med Sci (2021)
Country
Iran
Reported sample size
—
Source database
PubMed
PMID
33643566
PMCID
PMC7894631
DOI
10.22038/ijbms.2020.44409.10391

Abstract (original English)

Objectives Avocado/soybean unsaponifible (ASU) possesses properties including chondroprotective, anticatabolic, and anabolic. The goal behind this research was to detect the effect of ASU and TGF-β3 on the chondrogenesis of human adipose-derived stem cells (hADSCs) on poly (lactic-co-glycolic) acid (PLGA)/ hyaluronic acid (PLGA/HA) hybrid scaffold. Materials and methods First hADSCs were seeded in PLGA/Hyaluronic acid scaffold and cultured in chondrogenic media. These cells were assigned into 4 groups: control, TGFβ-3, ASU, and TGFβ-3+ASU. The viability was assessed separately by MTT. Real-time PCR was used to quantify the expression of chondrogenic specific genes [ Sox9, collagen type II (ColII), Aggrecan (AGG) ] and collagen type X (ColX) . Moreover, Western blotting was employed to evaluate protein expression levels of collagens type II and X. Results These findings indicated a significant increase in the proliferation and survival of hADSCs differentiated cells by ASU compared with the control group ( P =0.008). Real-time PCR results revealed significant differences in the expression of AGG , SOX9 , ColII , and ColX genes in the control group when compared with other groups (ASU, TGF-β3, and TGF-β3+ASU). ColII protein production significantly dropped in the TGF-β3 group in comparison with the TGF-β3+ASU group (0.000). The ColII ( P =0.002) and ColX ( P =0.002) protein produ

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.